Tapewire

Nasdaq · USD

CHRN

ChronoScale Holdings Corp

Export transactions ↓
Tapewire entity
4331
SEC CIK
0001549084
Parsed reports
210

Last 12 months

Inside the activity.

12 purchase rows · 6 sale rows

Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.
Monthly counts
MonthPurchasesSales
Nov 202503
Dec 202502
Jan 202601
Feb 2026100
Mar 202620
Apr 202600
May 202600
Jun 202600
Jul 202600
Aug 202600
Sep 202600
Oct 202600

Latest available

Insider transactions

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateOwner / reported roleActivity / securityShares / unitsReported priceReported valueDetails
August 10, 2023 Filed Mar 14, 2024 22:41 UTC PurchaseCommon Stock 4,201 $1.25 $5,251.25
Disclosure

SEC source: 0001437749-24-007906 · rdgdoc.xml · nonDerivative · entry 1

Lathan Corinna · CIK 0001714701 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 138,458

F1 · balance_after: Includes 67,392 unvested RSUs.

Read SEC document
June 12, 2023 Filed Jun 15, 2023 21:59 UTC
Jones Jason CChief Operating Officer
GrantCommon Stock 10,800 $0.00 $0.00
Disclosure

SEC source: 0001549084-23-000045 · wk-form4_1686880789.xml · nonDerivative · entry 5

Jones Jason C · CIK 0001775619 · Chief Operating Officer

10b5-1 filing: No plan indicated

Ownership: Indirect · By 401K

Disclosed balance after: 15,291

Read SEC document
June 12, 2023 Filed Jun 15, 2023 21:59 UTC
Jones Jason CChief Operating Officer
GrantCommon Stock 170,454 $0.00 $0.00
Disclosure

SEC source: 0001549084-23-000045 · wk-form4_1686880789.xml · nonDerivative · entry 2

Jones Jason C · CIK 0001775619 · Chief Operating Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 329,008

F1 · shares: Represents restricted stock units ("RSUs"). Each RSU represents the economic equivalent of one share of EKSO common stock and shall be settled in shares of EKSO common stock upon vesting.

F4 · shares: The RSU grant was approved by the Board of Directors in a meeting held on December 8, 2022, on the condition that the Issuer's stockholders approved an increase in shares available for issuance under the Issuer's Amended and Restated 2014 Equity Incentive Plan, which occurred at the Issuer's Annual Meeting on June 8, 2023, and the Issuer filed a registration statement on Form S-8 with the Securities and Exchange Commission, which occurred on June 12, 2023. 1/3 of the total number of shares of Common Stock subject to the RSUs will vest on each of January 3, 2024, 2025 and 2026, in each case subject to the Reporting Person's continuous service with the Issuer as of each vesting date.

F5 · balance_after: Includes 251,141 unvested RSUs.

Read SEC document
June 12, 2023 Filed Jun 15, 2023 21:59 UTC
Jones Jason CChief Operating Officer
GrantCommon Stock 20,000 $0.00 $0.00
Disclosure

SEC source: 0001549084-23-000045 · wk-form4_1686880789.xml · nonDerivative · entry 1

Jones Jason C · CIK 0001775619 · Chief Operating Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 158,554

F1 · shares: Represents restricted stock units ("RSUs"). Each RSU represents the economic equivalent of one share of EKSO common stock and shall be settled in shares of EKSO common stock upon vesting.

F2 · shares: The RSU grant was approved by the Board of Directors in a meeting held on December 8, 2022, on the condition that the Issuer's stockholders approved an increase in shares available for issuance under the Issuer's Amended and Restated 2014 Equity Incentive Plan, which occurred at the Issuer's Annual Meeting on June 8, 2023, and the Issuer filed a registration statement on Form S-8 with the Securities and Exchange Commission, which occurred on June 12, 2023. 1/3 of the total number of shares of Common Stock subject to the RSUs will vest on each of December 8, 2023, 2024 and 2025, in each case subject to the Reporting Person's continuous service with the Issuer as of each vesting date.

F3 · balance_after: Includes 80,867 unvested RSUs.

Read SEC document
June 12, 2023 Filed Jun 16, 2023 01:59 UTC
Wong JeromeChief Financial Officer
GrantCommon Stock 8,200 $0.00 $0.00
Disclosure

SEC source: 0001549084-23-000044 · wk-form4_1686880781.xml · nonDerivative · entry 2

Wong Jerome · CIK 0001932326 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Indirect · By 401(k)

Disclosed balance after: 11,413

Read SEC document
June 12, 2023 Filed Jun 16, 2023 01:59 UTC
Wong JeromeChief Financial Officer
GrantCommon Stock 170,068 $0.00 $0.00
Disclosure

SEC source: 0001549084-23-000044 · wk-form4_1686880781.xml · nonDerivative · entry 1

Wong Jerome · CIK 0001932326 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 271,537

F1 · shares: Represents restricted stock units ("RSUs"). Each RSU represents the economic equivalent of one share of EKSO common stock and shall be settled in shares of EKSO common stock upon vesting.

F2 · shares: The RSU grant was approved by the Compensation Committee of the Board of Directors in a meeting held on December 5, 2022, on the condition that the Issuer's stockholders approved an increase in shares available for issuance under the Issuer's Amended and Restated 2014 Equity Incentive Plan, which occurred at the Issuer's Annual Meeting on June 8, 2023, and the Issuer filed a registration statement on Form S-8 with the Securities and Exchange Commission, which occurred on June 12, 2023. 1/3 of the total number of shares of Common Stock subject to the RSUs will vest on each of December 5, 2023, 2024 and 2025, in each case subject to the Reporting Person's continuous service with the Issuer as of each vesting date.

F3 · balance_after: Includes 265,401 unvested RSUs.

Read SEC document
June 12, 2023 Filed Apr 4, 2024 21:21 UTC Amendment
Jones Jason CChief Operating Officer
GrantCommon Stock 10,800 $0.00 $0.00
Disclosure

SEC source: 0001437749-24-011125 · rdgdoc.xml · nonDerivative · entry 2

Jones Jason C · CIK 0001775619 · Chief Operating Officer

10b5-1 filing: No plan indicated

Ownership: Indirect · By 401(k)

Disclosed balance after: 15,391

F1 · balance_after: On June 15, 2023, the Reporting Person filed a Form 4 that stated the incorrect number of shares of common stock acquired in connection with the Issuer's 401(k) plan matching contribution which occurred on 2/17/2022. This amendment corrects such inaccuracy and the related total number of securities indirectly owned at that date and subsequently.

Read SEC document
June 08, 2023 Filed Jun 15, 2023 21:59 UTC
SHERMAN STEVENExecutive Chair
GrantCommon Stock 91,241 $0.00 $0.00
Disclosure

SEC source: 0001549084-23-000043 · wk-form4_1686880770.xml · nonDerivative · entry 1

SHERMAN STEVEN · CIK 0001201619 · Executive Chair

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 456,154

F1 · shares: Represents restricted stock units ("RSUs"). Each RSU represents the economic equivalent of one share of EKSO common stock and shall be settled in shares of EKSO common stock upon vesting.

F2 · shares: The RSUs were granted on June 8, 2023 (the "Grant Date"), in accordance with the terms of an Executive Employment Agreement entered into between the Reporting Person and the Issuer on December 5, 2022. The RSUs are scheduled to vest and settle at the earlier of the date of the next annual meeting of stockholders or the one-year anniversary of the Grant Date.

F3 · balance_after: Includes 91,241 unvested RSUs.

Read SEC document
June 08, 2023 Filed Jun 16, 2023 21:48 UTC GrantCommon Stock 72,993 $0.00 $0.00
Disclosure

SEC source: 0001549084-23-000048 · wk-form4_1686952119.xml · nonDerivative · entry 1

Lathan Corinna · CIK 0001714701 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 139,858

F1 · shares: Represents restricted stock units ("RSUs"). Each RSU represents the economic equivalent of one share of EKSO common stock and shall be settled in shares of EKSO common stock upon vesting.

F2 · shares: This award of RSUs was granted effective June 8, 2023, the date of the Issuer's 2023 Annual Meeting of Stockholders (the "Grant Date"), pursuant to an automatic annual non-employee director grant provision approved by the Company's Board of Directors on April 13, 2021. The RSUs are scheduled to vest and settle at the earlier of the date of the next annual meeting of stockholders or the one-year anniversary of the Grant Date.

F3 · balance_after: Includes 72,993 unvested RSUs.

Read SEC document
June 08, 2023 Filed Jun 16, 2023 21:49 UTC GrantCommon Stock 72,993 $0.00 $0.00
Disclosure

SEC source: 0001549084-23-000049 · wk-form4_1686952164.xml · nonDerivative · entry 1

Cloyd Mary Ann · CIK 0001666769 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 147,889

F1 · shares: Represents restricted stock units ("RSUs"). Each RSU represents the economic equivalent of one share of EKSO common stock and shall be settled in shares of EKSO common stock upon vesting.

F2 · shares: This award of RSUs was granted effective June 8, 2023, the date of the Issuer's 2023 Annual Meeting of Stockholders (the "Grant Date"), pursuant to an automatic annual non-employee director grant provision approved by the Company's Board of Directors on April 13, 2021. The RSUs are scheduled to vest and settle at the earlier of the date of the next annual meeting of stockholders or the one-year anniversary of the Grant Date.

F3 · balance_after: Includes 72,993 unvested RSUs.

Read SEC document
June 08, 2023 Filed Jun 16, 2023 21:47 UTC GrantCommon Stock 72,993 $0.00 $0.00
Disclosure

SEC source: 0001549084-23-000047 · wk-form4_1686952046.xml · nonDerivative · entry 1

Wallen Rhonda A. · CIK 0001838009 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 147,889

F1 · shares: Represents restricted stock units ("RSUs"). Each RSU represents the economic equivalent of one share of EKSO common stock and shall be settled in shares of EKSO common stock upon vesting.

F2 · shares: This award of RSUs was granted effective June 8, 2023, the date of the Issuer's 2023 Annual Meeting of Stockholders (the "Grant Date"), pursuant to an automatic annual non-employee director grant provision approved by the Company's Board of Directors on April 13, 2021. The RSUs are scheduled to vest and settle at the earlier of the date of the next annual meeting of stockholders or the one-year anniversary of the Grant Date.

F3 · balance_after: Includes 72,993 unvested RSUs.

Read SEC document
June 08, 2023 Filed Jun 16, 2023 21:45 UTC
Li KechengDirector
GrantCommon Stock 72,993 $0.00 $0.00
Disclosure

SEC source: 0001549084-23-000046 · wk-form4_1686951932.xml · nonDerivative · entry 1

Li Kecheng · CIK 0001735083 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 152,122

F1 · shares: Represents restricted stock units ("RSUs"). Each RSU represents the economic equivalent of one share of EKSO common stock and shall be settled in shares of EKSO common stock upon vesting.

F2 · shares: This award of RSUs was granted effective June 8, 2023, the date of the Issuer's 2023 Annual Meeting of Stockholders (the "Grant Date"), pursuant to an automatic annual non-employee director grant provision approved by the Company's Board of Directors on April 13, 2021. The RSUs are scheduled to vest and settle at the earlier of the date of the next annual meeting of stockholders or the one-year anniversary of the Grant Date.

F3 · balance_after: Includes 72,993 unvested RSUs.

Read SEC document
June 08, 2023 Filed Jun 28, 2023 00:06 UTC Amendment GrantCommon Stock 67,392 $0.00 $0.00
Disclosure

SEC source: 0001549084-23-000054 · wk-form4a_1687910803.xml · nonDerivative · entry 1

Lathan Corinna · CIK 0001714701 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 134,257

F1 · shares: Represents restricted stock units ("RSUs"). Each RSU represents the economic equivalent of one share of EKSO common stock and shall be settled in shares of EKSO common stock upon vesting.

F2 · shares: This award of RSUs was granted effective June 8, 2023, the date of the Issuer's 2023 Annual Meeting of Stockholders (the "Grant Date"), pursuant to an automatic annual non-employee director grant provision approved by the Company's Board of Directors on April 13, 2021. The RSUs are scheduled to vest and settle at the earlier of the date of the next annual meeting of stockholders or the one-year anniversary of the Grant Date.

F3 · balance_after: Includes 67,392 unvested RSUs.

Read SEC document
June 08, 2023 Filed Jun 28, 2023 00:08 UTC Amendment GrantCommon Stock 67,392 $0.00 $0.00
Disclosure

SEC source: 0001549084-23-000055 · wk-form4a_1687910874.xml · nonDerivative · entry 1

Cloyd Mary Ann · CIK 0001666769 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 142,288

F1 · shares: Represents restricted stock units ("RSUs"). Each RSU represents the economic equivalent of one share of EKSO common stock and shall be settled in shares of EKSO common stock upon vesting.

F2 · shares: This award of RSUs was granted effective June 8, 2023, the date of the Issuer's 2023 Annual Meeting of Stockholders (the "Grant Date"), pursuant to an automatic annual non-employee director grant provision approved by the Company's Board of Directors on April 13, 2021. The RSUs are scheduled to vest and settle at the earlier of the date of the next annual meeting of stockholders or the one-year anniversary of the Grant Date.

F3 · balance_after: Includes 67,392 unvested RSUs.

Read SEC document
June 08, 2023 Filed Jun 27, 2023 20:03 UTC Amendment
SHERMAN STEVENExecutive Chair
GrantCommon Stock 84,240 $0.00 $0.00
Disclosure

SEC source: 0001549084-23-000051 · wk-form4a_1687910627.xml · nonDerivative · entry 1

SHERMAN STEVEN · CIK 0001201619 · Executive Chair

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 449,153

F1 · shares: Represents restricted stock units ("RSUs"). Each RSU represents the economic equivalent of one share of EKSO common stock and shall be settled in shares of EKSO common stock upon vesting.

F2 · shares: The RSUs were granted on June 8, 2023 (the "Grant Date"), in accordance with the terms of an Executive Employment Agreement entered into between the Reporting Person and the Issuer on December 5, 2022. The RSUs are scheduled to vest and settle at the earlier of the date of the next annual meeting of stockholders or the one-year anniversary of the Grant Date.

F3 · balance_after: Includes 84,240 unvested RSUs.

Read SEC document
June 08, 2023 Filed Jun 28, 2023 00:06 UTC Amendment GrantCommon Stock 67,392 $0.00 $0.00
Disclosure

SEC source: 0001549084-23-000053 · wk-form4a_1687910753.xml · nonDerivative · entry 1

Wallen Rhonda A. · CIK 0001838009 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 142,288

F1 · shares: Represents restricted stock units ("RSUs"). Each RSU represents the economic equivalent of one share of EKSO common stock and shall be settled in shares of EKSO common stock upon vesting.

F2 · shares: This award of RSUs was granted effective June 8, 2023, the date of the Issuer's 2023 Annual Meeting of Stockholders (the "Grant Date"), pursuant to an automatic annual non-employee director grant provision approved by the Company's Board of Directors on April 13, 2021. The RSUs are scheduled to vest and settle at the earlier of the date of the next annual meeting of stockholders or the one-year anniversary of the Grant Date.

F3 · balance_after: Includes 67,392 unvested RSUs.

Read SEC document
June 08, 2023 Filed Jun 28, 2023 00:05 UTC Amendment
Li KechengDirector
GrantCommon Stock 67,392 $0.00 $0.00
Disclosure

SEC source: 0001549084-23-000052 · wk-form4a_1687910706.xml · nonDerivative · entry 1

Li Kecheng · CIK 0001735083 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 146,521

F1 · shares: Represents restricted stock units ("RSUs"). Each RSU represents the economic equivalent of one share of EKSO common stock and shall be settled in shares of EKSO common stock upon vesting.

F2 · shares: This award of RSUs was granted effective June 8, 2023, the date of the Issuer's 2023 Annual Meeting of Stockholders (the "Grant Date"), pursuant to an automatic annual non-employee director grant provision approved by the Company's Board of Directors on April 13, 2021. The RSUs are scheduled to vest and settle at the earlier of the date of the next annual meeting of stockholders or the one-year anniversary of the Grant Date.

F3 · balance_after: Includes 67,392 unvested RSUs.

Read SEC document
May 24, 2023 Filed May 26, 2023 18:45 UTC
SHERMAN STEVENExecutive Chair
SaleCommon Stock 45,660 $1.44 $65,873.68
Disclosure

SEC source: 0001549084-23-000035 · wk-form4_1685141113.xml · nonDerivative · entry 1

SHERMAN STEVEN · CIK 0001201619 · Executive Chair

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 364,913

F1 · shares: Represents shares sold by the Reporting Person on May 24, 2023 to cover tax withholding obligations incurred upon the vesting and settlement of the restricted stock award originally reported by the Reporting Person in Form 4 filed with the Commission on December 7, 2022.

F2 · price: These shares were sold in a single transaction at a price of $1.4427 per share.

Read SEC document
May 08, 2023 Filed May 17, 2023 19:42 UTC
Jones Jason CChief Operating Officer
SaleCommon Stock 3,435 $1.57 $5,400.85
Disclosure

SEC source: 0001549084-23-000031 · wk-form4_1684366930.xml · nonDerivative · entry 1

Jones Jason C · CIK 0001775619 · Chief Operating Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 138,554

F1 · shares: Represents shares sold by the Reporting Person on May 8, 2023 to cover tax withholding obligations incurred upon the vesting and settlement of the second installment of restricted stock awards originally reported by the Reporting Person in Form 4 filed with the Commission on March 5, 2021 and February 17, 2022.

F2 · price: These shares were sold in a single transaction at a price of $1.5723 per share.

Read SEC document
December 04, 2022 Filed Dec 6, 2022 19:03 UTC
Jones Jason CSenior VP Product Development
GrantCommon Stock 17,007 $0.00 $0.00
Disclosure

SEC source: 0001549084-22-000076 · wf-form4_167037137144167.xml · nonDerivative · entry 1

Jones Jason C · CIK 0001775619 · Senior VP Product Development

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 141,989

F1 · shares: The grant of restricted stock units ("RSUs") was approved by the Issuer's Compensation Committee of the Board of Directors on December 4, 2022 in accordance with the terms of the Issuer's Amended and Restated 2014 Equity Incentive Plan. Each RSU represents the economic equivalent of one share of the Issuer's common stock and shall be settled in shares of the Issuer's common stock upon vesting. One-third of the RSUs shall vest on each of the first three anniversaries of the grant date, subject to the Reporting Person continuing to be a Service Provider (as defined under the Plan) through such date.

F2 · balance_after: Includes 43,680 unvested RSUs.

Read SEC document
December 04, 2022 Filed Dec 6, 2022 19:04 UTC GrantCommon Stock 87,787 $0.00 $0.00
Disclosure

SEC source: 0001549084-22-000077 · wf-form4_167037143718276.xml · nonDerivative · entry 1

Stern Stanley · CIK 0001316499 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 167,008

F1 · shares: The grant of restricted stock units ("RSUs") was approved by the Issuer's Board of Directors on December 4, 2022 in accordance with the terms of the Issuer's Amended and Restated 2014 Equity Incentive Plan. Each RSU represents the economic equivalent of one share of the Issuer's common stock and shall be settled in shares of the Issuer's common stock upon vesting. The RSUs fully vested on December 4, 2022 and were delivered to the Reporting Person upon settlement.

F2 · balance_after: Includes 51,721 unvested RSUs.

Read SEC document
December 04, 2022 Filed Dec 7, 2022 21:09 UTC
SHERMAN STEVENDirector · Executive Chair
Exercise / conversionRestricted Stock Units · Derivative 31,198 $0.00 $0.00
Disclosure

SEC source: 0001549084-22-000078 · wf-form4_167046533623014.xml · derivative · entry 4

SHERMAN STEVEN · CIK 0001201619 · Director · Executive Chair

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 31,198 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F5 · derivative.exercise_price: The restricted stock units ("RSUs") were granted on March 8, 2022 in accordance with the terms of an Executive Employment Agreement entered into between the Reporting Person and the Company on January 21, 2022 (the "Effective Date").

F6 · derivative.exercise_date: On December 4, 2022, the Issuer's Board of Directors approved an amendment to the vesting schedule of the RSUs such that the RSUs fully vested and were delivered to the Reporting Person upon settlement.

F6 · derivative.expiration_date: On December 4, 2022, the Issuer's Board of Directors approved an amendment to the vesting schedule of the RSUs such that the RSUs fully vested and were delivered to the Reporting Person upon settlement.

Read SEC document
December 04, 2022 Filed Dec 7, 2022 21:09 UTC
SHERMAN STEVENDirector · Executive Chair
GrantCommon Stock 242,679 $0.00 $0.00
Disclosure

SEC source: 0001549084-22-000078 · wf-form4_167046533623014.xml · nonDerivative · entry 3

SHERMAN STEVEN · CIK 0001201619 · Director · Executive Chair

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 971,343

F3 · shares: The grant of restricted stock units ("RSUs") was approved by the Issuer's Board of Directors on December 4, 2022 in accordance with the terms of the Issuer's Amended and Restated 2014 Equity Incentive Plan. Each RSU represents the economic equivalent of one share of the Issuer's common stock and shall be settled in shares of the Issuer's common stock upon vesting. The RSUs shall fully vest on January 31, 2023.

F4 · balance_after: Includes 242,579 unvested RSUs.

Read SEC document
December 04, 2022 Filed Dec 7, 2022 21:09 UTC
SHERMAN STEVENDirector · Executive Chair
SaleCommon Stock 10,576 $1.28 $13,491.80
Disclosure

SEC source: 0001549084-22-000078 · wf-form4_167046533623014.xml · nonDerivative · entry 2

SHERMAN STEVEN · CIK 0001201619 · Director · Executive Chair

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 728,664

F1 · shares: Represents shares sold by the Reporting Person on December 7, 2022 to cover tax withholding obligations incurred upon the vesting and settlement of the remaining securities under a restricted stock award originally reported by the Reporting Person in Form 4 filed with the Commission on March 10, 2022.

F2 · price: The sale price represents the weighted average sale price per share. The shares were sold in multiple transactions at prices ranging from $1.2700 to $1.3310, inclusive. The Company can provide the full information regarding the number of shares sold at each separate price upon further request.

Read SEC document
December 04, 2022 Filed Dec 7, 2022 21:09 UTC
SHERMAN STEVENDirector · Executive Chair
Exercise / conversionCommon Stock 31,198 $0.00 $0.00
Disclosure

SEC source: 0001549084-22-000078 · wf-form4_167046533623014.xml · nonDerivative · entry 1

SHERMAN STEVEN · CIK 0001201619 · Director · Executive Chair

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 739,240

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
November 21, 2022 Filed Nov 23, 2022 15:17 UTC
SHERMAN STEVENDirector · CEO & Chairman
Exercise / conversionRestricted Stock Units · Derivative 15,599 $0.00 $0.00
Disclosure

SEC source: 0001549084-22-000073 · wf-form4_166923460573290.xml · derivative · entry 3

SHERMAN STEVEN · CIK 0001201619 · Director · CEO & Chairman

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 31,199

Underlying: Common Stock · 15,599 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · derivative.exercise_price: The restricted stock units ("RSUs") were granted on March 8, 2022 in accordance with the terms of an Executive Employment Agreement entered into between the Reporting Person and the Company on January 21, 2022 (the "Effective Date").

F4 · derivative.exercise_date: The RSUs vest in twelve equal installments on the first twelve monthly anniversaries of the Effective Date, starting February 21, 2022, such that the RSUs will be fully vested as of January 21, 2023. The tenth installment of RSUs vested on November 21, 2022 and were delivered to the Reporting Person upon settlement.

F4 · derivative.expiration_date: The RSUs vest in twelve equal installments on the first twelve monthly anniversaries of the Effective Date, starting February 21, 2022, such that the RSUs will be fully vested as of January 21, 2023. The tenth installment of RSUs vested on November 21, 2022 and were delivered to the Reporting Person upon settlement.

Read SEC document
November 21, 2022 Filed Nov 23, 2022 15:17 UTC
SHERMAN STEVENDirector · CEO & Chairman
SaleCommon Stock 5,787 $1.26 $7,312.45
Disclosure

SEC source: 0001549084-22-000073 · wf-form4_166923460573290.xml · nonDerivative · entry 2

SHERMAN STEVEN · CIK 0001201619 · Director · CEO & Chairman

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 708,042

F1 · shares: Represents shares sold by the Reporting Person on November 22, 2022 to cover tax withholding obligations incurred upon the vesting and settlement of the tenth installment of a restricted stock award originally reported by the Reporting Person in Form 4 filed with the Commission on March 10, 2022

F2 · price: The sale price represents the weighted average sale price per share. The shares were sold in multiple transactions at prices ranging from $1.26 to $1.27, inclusive. The Company can provide the full information regarding the number of shares sold at each separate price upon further request.

Read SEC document
November 21, 2022 Filed Nov 23, 2022 15:17 UTC
SHERMAN STEVENDirector · CEO & Chairman
Exercise / conversionCommon Stock 15,599 $0.00 $0.00
Disclosure

SEC source: 0001549084-22-000073 · wf-form4_166923460573290.xml · nonDerivative · entry 1

SHERMAN STEVEN · CIK 0001201619 · Director · CEO & Chairman

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 713,829

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
November 16, 2022 Filed Nov 17, 2022 17:49 UTC
Jones Jason CSenior VP Product Development
SaleCommon Stock 782 $1.28 $1,002.92
Disclosure

SEC source: 0001549084-22-000072 · wf-form4_166872531979939.xml · nonDerivative · entry 1

Jones Jason C · CIK 0001775619 · Senior VP Product Development

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 124,982

F1 · shares: Represents shares sold by the Reporting Person on November 16, 2022 to cover tax withholding obligations incurred upon the vesting and settlement of the third installment of a restricted stock award originally reported by the Reporting Person in Form 4 filed with the Commission on April 2, 2020

F2 · price: These shares were sold in a single transaction at a price of $1.2825 per share.

Read SEC document
November 16, 2022 Filed Nov 17, 2022 22:47 UTC
Wong JeromeChief Financial Officer
SaleCommon Stock 723 $1.28 $927.25
Disclosure

SEC source: 0001932326-22-000009 · wf-form4_166872521232303.xml · nonDerivative · entry 1

Wong Jerome · CIK 0001932326 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 101,469

F1 · shares: Represents shares sold by the Reporting Person on November 16, 2022 to cover tax withholding obligations incurred upon the vesting and settlement of the third installment of a restricted stock award originally reported by the Reporting Person in Form 3 filed with the Commission on June 22, 2022

F2 · price: These shares were sold in a single transaction at a price of $1.2825 per share.

Read SEC document
October 24, 2022 Filed Oct 26, 2022 18:31 UTC
SHERMAN STEVENDirector · CEO & Chairman
SaleCommon Stock 5,921 $1.29 $7,619.14
Disclosure

SEC source: 0001549084-22-000060 · wf-form4_166682345219861.xml · nonDerivative · entry 2

SHERMAN STEVEN · CIK 0001201619 · Director · CEO & Chairman

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 698,230

F1 · shares: Represents shares sold by the Reporting Person on October 24, 2022 to cover tax withholding obligations incurred upon the vesting and settlement of the ninth installment of a restricted stock award originally reported by the Reporting Person in Form 4 filed with the Commission on March 10, 2022

F2 · price: These shares were sold in a single transaction at a price of $1.2868 per share.

Read SEC document
October 21, 2022 Filed Oct 26, 2022 18:31 UTC
SHERMAN STEVENDirector · CEO & Chairman
Exercise / conversionRestricted Stock Units · Derivative 15,600 $0.00 $0.00
Disclosure

SEC source: 0001549084-22-000060 · wf-form4_166682345219861.xml · derivative · entry 3

SHERMAN STEVEN · CIK 0001201619 · Director · CEO & Chairman

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 46,798

Underlying: Common Stock · 15,600 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · derivative.exercise_price: The restricted stock units ("RSUs") were granted on March 8, 2022 in accordance with the terms of an Executive Employment Agreement entered into between the Reporting Person and the Company on January 21, 2022 (the "Effective Date").

F4 · derivative.exercise_date: The RSUs vest in twelve equal installments on the first twelve monthly anniversaries of the Effective Date, starting February 21, 2022, such that the RSUs will be fully vested as of January 21, 2023. The ninth installment of RSUs vested on October 21, 2022 and were delivered to the Reporting Person upon settlement.

F4 · derivative.expiration_date: The RSUs vest in twelve equal installments on the first twelve monthly anniversaries of the Effective Date, starting February 21, 2022, such that the RSUs will be fully vested as of January 21, 2023. The ninth installment of RSUs vested on October 21, 2022 and were delivered to the Reporting Person upon settlement.

Read SEC document
October 21, 2022 Filed Oct 26, 2022 18:31 UTC
SHERMAN STEVENDirector · CEO & Chairman
Exercise / conversionCommon Stock 15,600 $0.00 $0.00
Disclosure

SEC source: 0001549084-22-000060 · wf-form4_166682345219861.xml · nonDerivative · entry 1

SHERMAN STEVEN · CIK 0001201619 · Director · CEO & Chairman

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 704,151

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
September 22, 2022 Filed Sep 26, 2022 19:20 UTC
SHERMAN STEVENDirector · CEO & Chairman
SaleCommon Stock 6,043 $1.75 $10,552.89
Disclosure

SEC source: 0001549084-22-000058 · wf-form4_166423443179228.xml · nonDerivative · entry 2

SHERMAN STEVEN · CIK 0001201619 · Director · CEO & Chairman

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 688,551

F1 · shares: Represents shares sold by the Reporting Person on September 22, 2022 to cover tax withholding obligations incurred upon the vesting and settlement of the eighth installment of a restricted stock award originally reported by the Reporting Person in Form 4 filed with the Commission on March 10, 2022.

F2 · price: The sale price represents the weighted average sale price per share. The shares were sold in multiple transactions at prices ranging from $1.70 to $1.80, inclusive. The Company can provide the full information regarding the number of shares sold at each separate price upon further request.

Read SEC document
September 21, 2022 Filed Sep 26, 2022 19:20 UTC
SHERMAN STEVENDirector · CEO & Chairman
Exercise / conversionRestricted Stock Units · Derivative 15,599 $0.00 $0.00
Disclosure

SEC source: 0001549084-22-000058 · wf-form4_166423443179228.xml · derivative · entry 3

SHERMAN STEVEN · CIK 0001201619 · Director · CEO & Chairman

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 62,398

Underlying: Common Stock · 15,599 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · derivative.exercise_price: The restricted stock units ("RSUs") were granted on March 8, 2022 in accordance with the terms of an Executive Employment Agreement entered into between the Reporting Person and the Company on January 21, 2022 (the "Effective Date").

F4 · derivative.exercise_date: The RSUs vest in twelve equal installments on the first twelve monthly anniversaries of the Effective Date, starting February 21, 2022, such that the RSUs will be fully vested as of January 21, 2023. The eighth installment of RSUs vested on September 22, 2022 and were delivered to the Reporting Person upon settlement.

F4 · derivative.expiration_date: The RSUs vest in twelve equal installments on the first twelve monthly anniversaries of the Effective Date, starting February 21, 2022, such that the RSUs will be fully vested as of January 21, 2023. The eighth installment of RSUs vested on September 22, 2022 and were delivered to the Reporting Person upon settlement.

Read SEC document
September 21, 2022 Filed Sep 26, 2022 19:20 UTC
SHERMAN STEVENDirector · CEO & Chairman
Exercise / conversionCommon Stock 15,599 $0.00 $0.00
Disclosure

SEC source: 0001549084-22-000058 · wf-form4_166423443179228.xml · nonDerivative · entry 1

SHERMAN STEVEN · CIK 0001201619 · Director · CEO & Chairman

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 694,594

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
August 31, 2022 Filed Sep 2, 2022 17:50 UTC
Jones Jason CSenior VP Product Development
SaleCommon Stock 5,873 $2.31 $13,586.60
Disclosure

SEC source: 0001549084-22-000055 · wf-form4_166215543317641.xml · nonDerivative · entry 1

Jones Jason C · CIK 0001775619 · Senior VP Product Development

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 125,764

F1 · shares: Represents shares sold by the Reporting Person on August 31, 2022 to cover tax withholding obligations incurred upon the vesting and settlement of the first installment of a restricted stock award originally reported by the Reporting Person in Form 4 filed with the Commission on April 11, 2022

F2 · price: The sale price represents the weighted average sale price per share. The shares were sold in multiple transactions at prices ranging from $2.31 to $2.32, inclusive. The Company can provide the full information regarding the number of shares sold at each separate price upon further request.

Read SEC document
August 22, 2022 Filed Aug 23, 2022 15:09 UTC
SHERMAN STEVENDirector · CEO & Chairman
SaleCommon Stock 5,572 $2.20 $12,278.46
Disclosure

SEC source: 0001549084-22-000053 · wf-form4_166128175210388.xml · nonDerivative · entry 2

SHERMAN STEVEN · CIK 0001201619 · Director · CEO & Chairman

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 678,995

F1 · shares: Represents shares sold by the Reporting Person on August 22, 2022 to cover tax withholding obligations incurred upon the vesting and settlement of the seventh installment of a restricted stock award originally reported by the Reporting Person in Form 4 filed with the Commission on March 10, 2022

F2 · price: The sale price represents the weighted average sale price per share. The shares were sold in multiple transactions at prices ranging from $2.24 to $2.20, inclusive. The Company can provide the full information regarding the number of shares sold at each separate price upon further request.

Read SEC document
August 21, 2022 Filed Aug 23, 2022 15:09 UTC
SHERMAN STEVENDirector · CEO & Chairman
Exercise / conversionRestricted Stock Units · Derivative 15,599 $0.00 $0.00
Disclosure

SEC source: 0001549084-22-000053 · wf-form4_166128175210388.xml · derivative · entry 3

SHERMAN STEVEN · CIK 0001201619 · Director · CEO & Chairman

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 77,997

Underlying: Common Stock · 15,599 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · derivative.exercise_price: The restricted stock units ("RSUs") were granted on March 8, 2022 in accordance with the terms of an Executive Employment Agreement entered into between the Reporting Person and the Company on January 21, 2022 (the "Effective Date").

F4 · derivative.exercise_date: The RSUs vest in twelve equal installments on the first twelve monthly anniversaries of the Effective Date, starting February 21, 2022, such that the RSUs will be fully vested as of January 21, 2023. The seventh installment of RSUs vested on August 21, 2022 and were delivered to the Reporting Person upon settlement.

F4 · derivative.expiration_date: The RSUs vest in twelve equal installments on the first twelve monthly anniversaries of the Effective Date, starting February 21, 2022, such that the RSUs will be fully vested as of January 21, 2023. The seventh installment of RSUs vested on August 21, 2022 and were delivered to the Reporting Person upon settlement.

Read SEC document
August 21, 2022 Filed Aug 23, 2022 15:09 UTC
SHERMAN STEVENDirector · CEO & Chairman
Exercise / conversionCommon Stock 15,599 $0.00 $0.00
Disclosure

SEC source: 0001549084-22-000053 · wf-form4_166128175210388.xml · nonDerivative · entry 1

SHERMAN STEVEN · CIK 0001201619 · Director · CEO & Chairman

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 684,567

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
August 03, 2022 Filed Aug 4, 2022 23:56 UTC
Wong JeromeInterimChief Financial Officer
SaleCommon Stock 1,675 $1.80 $3,021.37
Disclosure

SEC source: 0001932326-22-000007 · wf-form4_165965730720313.xml · nonDerivative · entry 1

Wong Jerome · CIK 0001932326 · InterimChief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 102,192

F1 · shares: Represents shares sold by the Reporting Person on August 3, 2022 to cover tax withholding obligations incurred upon the vesting and settlement of a restricted stock award originally reported by the Reporting Person in Form 3 filed with the Commission on June 22, 2022.

F2 · price: These shares were sold in a single transaction at a price of $1.8038 per share.

Read SEC document
July 25, 2022 Filed Jul 25, 2022 20:27 UTC
SHERMAN STEVENDirector · CEO & Chairman
SaleCommon Stock 5,662 $1.75 $9,908.50
Disclosure

SEC source: 0001549084-22-000042 · wf-form4_165879520489061.xml · nonDerivative · entry 2

SHERMAN STEVEN · CIK 0001201619 · Director · CEO & Chairman

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 668,968

F1 · shares: Represents shares sold by the Reporting Person on July 25, 2022 to cover tax withholding obligations incurred upon the vesting and settlement of the sixth installment of a restricted stock award originally reported by the Reporting Person in Form 4 filed with the Commission on March 10, 2022

F2 · price: These shares were sold in a single transaction at a price of $1.75 per share.

Read SEC document
July 21, 2022 Filed Jul 25, 2022 20:27 UTC
SHERMAN STEVENDirector · CEO & Chairman
Exercise / conversionRestricted Stock Units · Derivative 15,599 $0.00 $0.00
Disclosure

SEC source: 0001549084-22-000042 · wf-form4_165879520489061.xml · derivative · entry 3

SHERMAN STEVEN · CIK 0001201619 · Director · CEO & Chairman

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 93,596

Underlying: Common Stock · 15,599 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · derivative.exercise_price: The restricted stock units ("RSUs") were granted on March 8, 2022 in accordance with the terms of an Executive Employment Agreement entered into between the Reporting Person and the Company on January 21, 2022 (the "Effective Date").

F4 · derivative.exercise_date: The RSUs vest in twelve equal installments on the first twelve monthly anniversaries of the Effective Date, starting February 21, 2022, such that the RSUs will be fully vested as of January 21, 2023. The sixth installment of RSUs vested on July 21, 2022 and were delivered to the Reporting Person upon settlement.

F4 · derivative.expiration_date: The RSUs vest in twelve equal installments on the first twelve monthly anniversaries of the Effective Date, starting February 21, 2022, such that the RSUs will be fully vested as of January 21, 2023. The sixth installment of RSUs vested on July 21, 2022 and were delivered to the Reporting Person upon settlement.

Read SEC document
July 21, 2022 Filed Jul 25, 2022 20:27 UTC
SHERMAN STEVENDirector · CEO & Chairman
Exercise / conversionCommon Stock 15,599 $0.00 $0.00
Disclosure

SEC source: 0001549084-22-000042 · wf-form4_165879520489061.xml · nonDerivative · entry 1

SHERMAN STEVEN · CIK 0001201619 · Director · CEO & Chairman

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 674,630

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
July 18, 2022 Filed Jul 20, 2022 20:01 UTC
Wong JeromeInterimChief Financial Officer
SaleCommon Stock 98 $1.71 $167.13
Disclosure

SEC source: 0001932326-22-000005 · wf-form4_165834726686789.xml · nonDerivative · entry 1

Wong Jerome · CIK 0001932326 · InterimChief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 103,867

F1 · shares: Represents shares sold by the Reporting Person on July 18, 2022 to cover tax withholding obligations incurred upon the vesting and settlement of a restricted stock award originally reported by the Reporting Person in Form 3 filed with the Commission on June 22, 2022.

F2 · price: These shares were sold in a single transaction at a price of $1.7054 per share.

Read SEC document
June 30, 2022 Filed Jul 6, 2022 01:39 UTC
Davis Scott G.President & COO
SaleCommon Stock 4,997 $1.72 $8,594.84
Disclosure

SEC source: 0001908860-22-000002 · wf-form4_165707154717564.xml · nonDerivative · entry 1

Davis Scott G. · CIK 0001908860 · President & COO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 368,818

F1 · shares: Represents shares sold by the Reporting Person on June 30, 2022 to cover tax withholding obligations incurred upon the vesting and settlement of a restricted stock award originally reported by the Reporting Person in Form 3 filed with the Commission on February 3, 2022

F2 · price: These shares were sold in a single transaction at a price of $1.72 per share.

Read SEC document
June 22, 2022 Filed Jun 22, 2022 20:14 UTC
SHERMAN STEVENDirector · CEO & Chairman
SaleCommon Stock 5,330 $1.74 $9,259.28
Disclosure

SEC source: 0001549084-22-000037 · wf-form4_165594324527833.xml · nonDerivative · entry 2

SHERMAN STEVEN · CIK 0001201619 · Director · CEO & Chairman

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 659,031

F1 · shares: Represents shares sold by the Reporting Person on June 22, 2022 to cover tax withholding obligations incurred upon the vesting and settlement of the fifth installment of a restricted stock award originally reported by the Reporting Person in Form 4 filed with the Commission on March 10, 2022

F2 · price: These shares were sold in a single transaction at a price of $1.7372 per share.

Read SEC document
June 21, 2022 Filed Jun 22, 2022 20:14 UTC
SHERMAN STEVENDirector · CEO & Chairman
Exercise / conversionRestricted Stock Units · Derivative 15,599 $0.00 $0.00
Disclosure

SEC source: 0001549084-22-000037 · wf-form4_165594324527833.xml · derivative · entry 3

SHERMAN STEVEN · CIK 0001201619 · Director · CEO & Chairman

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 109,195

Underlying: Common Stock · 15,599 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · derivative.exercise_price: The restricted stock units ("RSUs") were granted on March 8, 2022 in accordance with the terms of an Executive Employment Agreement entered into between the Reporting Person and the Company on January 21, 2022 (the "Effective Date").

F4 · derivative.exercise_date: The RSUs vest in twelve equal installments on the first twelve monthly anniversaries of the Effective Date, starting February 21, 2022, such that the RSUs will be fully vested as of January 21, 2023. The fifth installment of RSUs vested on June 21, 2022 and were delivered to the Reporting Person upon settlement.

F4 · derivative.expiration_date: The RSUs vest in twelve equal installments on the first twelve monthly anniversaries of the Effective Date, starting February 21, 2022, such that the RSUs will be fully vested as of January 21, 2023. The fifth installment of RSUs vested on June 21, 2022 and were delivered to the Reporting Person upon settlement.

Read SEC document
June 21, 2022 Filed Jun 22, 2022 20:14 UTC
SHERMAN STEVENDirector · CEO & Chairman
Exercise / conversionCommon Stock 15,599 $0.00 $0.00
Disclosure

SEC source: 0001549084-22-000037 · wf-form4_165594324527833.xml · nonDerivative · entry 1

SHERMAN STEVEN · CIK 0001201619 · Director · CEO & Chairman

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 664,361

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
June 17, 2022 Filed Jun 22, 2022 22:17 UTC
Wong JeromeInterimChief Financial Officer
GrantCommon Stock 83,333 $0.00 $0.00
Disclosure

SEC source: 0001932326-22-000003 · wf-form4_165593623044240.xml · nonDerivative · entry 1

Wong Jerome · CIK 0001932326 · InterimChief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 103,965

F1 · security: Represents restricted stock units ("RSUs"). Each RSU represents the economic equivalent of one share of EKSO common stock and shall be settled in shares of EKSO common stock upon vesting.

F2 · date: The RSU grant was approved by the Board of Directors in a meeting held on May 25, 2022 in connection with the Reporting Person's appointment as the Company's interim Chief Financial Officer, effective from June 17, 2022.

F3 · shares: Represents the amount of RSUs equal to $150,000 divided by the closing price of the Company's stock on June 17, 2022 of $1.80. 1/3 of the total number of shares of Common Stock subject to the RSUs will vest on each of June 17, 2023, 2024 and 2025, in each case subject to the Reporting Person's continuous service with the issuer as of each vesting date.

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.